TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
14 juil. 2023 16h30 HE
|
Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...